Last 7 days
-3.2%
Last 30 days
-0.2%
Last 90 days
12.5%
Trailing 12 Months
-5.4%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 404.8B | 94.9B | -5.16% | -10.64% | 22.56 | 4.26 | 1.25% | -14.07% |
LLY | 296.8B | 28.5B | -5.67% | 20.74% | 47.53 | 10.4 | 0.79% | 11.88% |
MRK | 272.8B | 59.3B | -1.75% | 40.02% | 17.88 | 4.63 | 21.72% | 11.27% |
PFE | 226.4B | 100.3B | -8.43% | -20.95% | 7.22 | 2.26 | 23.43% | 42.74% |
BMY | 142.7B | 46.2B | -7.78% | -1.12% | 22.55 | 3.09 | -0.49% | -9.54% |
MID-CAP | ||||||||
PRGO | 4.8B | 4.5B | -0.20% | -5.41% | -34.17 | 1.08 | 7.56% | -104.06% |
RETA | 3.3B | 2.2M | 105.10% | 171.03% | -10.52 | 1.5K | -80.71% | -4.88% |
SMALL-CAP | ||||||||
SUPN | 1.9B | 667.2M | -9.96% | 17.66% | 31.57 | 2.87 | 15.09% | 13.64% |
TLRY | 1.6B | 602.5M | -17.77% | -52.80% | -2.74 | 2.63 | 18.18% | -18.59% |
CGC | 991.7M | 478.9M | -11.35% | -65.42% | -0.32 | 2.07 | -31.50% | -634.70% |
INVA | 792.9M | 285.2M | -7.22% | -37.95% | 3.6 | 2.78 | -27.21% | -40.28% |
CRON | 768.8M | 114.5M | -15.28% | -37.42% | -4.56 | 6.72 | 27.90% | 57.40% |
ACRS | 541.5M | 29.8M | -40.95% | -47.43% | -6.23 | 18.2 | 340.05% | 4.35% |
OCUL | 400.7M | 51.5M | -2.49% | -0.39% | -5.64 | 7.78 | 18.32% | -984.05% |
ENDP | 94.1M | 2.3B | -43.99% | -88.43% | -0.03 | 0.04 | -22.53% | -376.66% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 1.1% | 4,452 | 4,401 | 4,344 | 4,203 | 4,139 |
Gross Profit | 1.4% | 1,455 | 1,435 | 1,409 | 1,386 | 1,416 |
Operating Expenses | 2.7% | 1,377 | 1,341 | 909 | 1,005 | 1,006 |
S&GA Expenses | 4.0% | 585 | 562 | 548 | 537 | 536 |
R&D Expenses | 1.8% | 123 | 121 | 119 | 120 | 122 |
Interest Expenses | -7.1% | -156 | -145 | -135 | -128 | -125 |
Net Income | -31.0% | -140 | -107 | -116 | -109 | -68.90 |
Net Income Margin | -29.6% | -0.03* | -0.02* | -0.03* | -0.03* | - |
Free Cahsflow | 320.4% | 211 | -95.70 | 168 | 108 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 3.2% | 11,017 | 10,678 | 10,920 | 10,390 | 10,426 |
Current Assets | 5.3% | 2,720 | 2,583 | 2,652 | 3,936 | 3,860 |
Cash Equivalents | 28.2% | 601 | 469 | 485 | 1,966 | 1,865 |
Inventory | 6.0% | 1,150 | 1,085 | 1,080 | 1,022 | 1,020 |
Net PPE | 10.3% | 926 | 840 | 840 | 846 | 864 |
Goodwill | -2.4% | 3,429 | 3,515 | 2,971 | 2,999 | - |
Liabilities | 1.7% | 6,175 | 6,075 | 6,070 | 5,285 | 5,274 |
Current Liabilities | 9.7% | 1,114 | 1,015 | 1,015 | 981 | 1,588 |
LT Debt, Current | 8.1% | 36.00 | 34.00 | 31.00 | 5.00 | 604 |
LT Debt, Non Current | -0.2% | 4,070 | 4,078 | 4,086 | 3,511 | 2,917 |
Shareholder's Equity | 5.2% | 4,842 | 4,603 | 4,850 | 5,105 | 5,152 |
Retained Earnings | -1.2% | -2,067 | -2,043 | -1,994 | -1,929 | -1,927 |
Shares Outstanding | 0% | 135 | 135 | 134 | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 1820.6% | 307 | 16.00 | 301 | 235 | 156 |
Share Based Compensation | -3.0% | 55.00 | 57.00 | 58.00 | 61.00 | 60.00 |
Cashflow From Investing | 0.8% | -1,958 | -1,974 | -500 | 1,453 | 1,276 |
Cashflow From Financing | 3.8% | 422 | 406 | 413 | -187 | -178 |
Dividend Payments | 2.6% | 142 | 139 | 134 | 131 | 130 |
Buy Backs | NaN% | 0.00 | 0.00 | - | - | - |
87.3%
37.7%
18.9%
Y-axis is the maximum loss one would have experienced if Perrigo Company was unfortunately bought at previous high price.
-10.2%
-16.0%
-14.5%
-6.8%
FIve years rolling returns for Perrigo Company.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 2.04 | -901,717 | 35,822,300 | 0.04% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 108 | 46,000 | 91,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 6.81 | 20,553 | 987,553 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | added | 3.9 | -808 | 58,192 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 9.12 | 31,000 | 735,000 | 0.01% |
2023-02-21 | Insight Advisors, LLC/ PA | new | - | 301,350 | 301,350 | 0.10% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -1.2 | -472,000 | 7,159,000 | 0.01% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | new | - | 3,579 | 3,579 | -% |
2023-02-17 | Coppell Advisory Solutions Corp. | new | - | 205 | 205 | -% |
2023-02-17 | TRUIST FINANCIAL CORP | reduced | -19.37 | -2,125,390 | 7,150,610 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 15, 2023 | barrow hanley mewhinney & strauss llc | 7.30% | 9,825,539 | SC 13G | |
Feb 14, 2023 | price t rowe associates inc /md/ | 0.1% | 78,305 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 0.1% | 78,305 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.84% | 14,590,276 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.8% | 13,221,594 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 8.0% | 10,721,574 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.6% | 11,557,239 | SC 13G/A | |
Jan 10, 2022 | barrow hanley mewhinney & strauss llc | 10.10% | 13,505,133 | SC 13G | |
Nov 10, 2021 | price t rowe associates inc /md/ | 8.4% | 11,328,393 | SC 13G/A | |
Sep 10, 2021 | price t rowe associates inc /md/ | 18.0% | 24,135,892 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 17.39 -48.82% | 19.63 -42.23% | 23.67 -30.34% | 26.94 -20.72% | 29.79 -12.33% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | PRE 14A | PRE 14A | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-13 | Farrington Thomas | sold | -132,435 | 35.572 | -3,723 | evp and cio |
2023-03-10 | Dillard James E III | sold | -321,309 | 35.701 | -9,000 | evp & president csca |
2023-03-08 | Janish Ronald Craig | sold | -166,133 | 36.9185 | -4,500 | evp, gbl ops & sc & cto |
2023-03-07 | Quinn Grainne | acquired | 84,847 | 37.71 | 2,250 | evp, chief medical officer |
2023-03-07 | Willis Robert | sold (taxes) | -42,423 | 37.71 | -1,125 | evp & chro |
2023-03-07 | Quinn Grainne | sold (taxes) | -44,120 | 37.71 | -1,170 | evp, chief medical officer |
2023-03-07 | Janish Ronald Craig | acquired | 110,943 | 37.71 | 2,942 | evp, gbl ops & sc & cto |
2023-03-07 | Ives Alison | acquired | 65,841 | 37.71 | 1,746 | evp & chief scientific officer |
2023-03-07 | Farrington Thomas | sold (taxes) | -43,705 | 37.71 | -1,159 | evp and cio |
2023-03-07 | KESSLER MURRAY S | sold (taxes) | -446,864 | 37.71 | -11,850 | ceo |
Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net sales | $ 4,451.6 | $ 4,138.7 | $ 4,088.2 |
Cost of sales | 2,996.2 | 2,722.5 | 2,593.3 |
Gross profit | 1,455.4 | 1,416.2 | 1,494.9 |
Operating expenses | |||
Distribution | 113.0 | 93.0 | 85.1 |
Research and development | 123.1 | 122.0 | 121.7 |
Selling | 584.8 | 536.4 | 545.5 |
Administration | 512.3 | 482.0 | 478.5 |
Impairment charges | 0.0 | 173.1 | 0.0 |
Restructuring | 42.5 | 16.9 | 3.2 |
Other operating expense (income), net | 0.8 | (417.6) | (4.3) |
Total operating expenses | 1,376.5 | 1,005.8 | 1,229.7 |
Operating income | 78.9 | 410.4 | 265.2 |
Change in financial assets | 0.0 | 0.0 | 95.3 |
Interest expense, net | 156.0 | 125.0 | 127.7 |
Other (income) expense, net | 53.1 | 26.7 | 16.3 |
Loss on extinguishment of debt | 8.9 | 0.0 | 20.0 |
Income (loss) from continuing operations before income taxes | (139.1) | 258.7 | 5.9 |
Income tax expense (benefit) | (8.2) | 389.6 | (38.3) |
Income (loss) from continuing operations | (130.9) | (130.9) | 44.2 |
Income (loss) from discontinued operations, net of tax | (9.7) | 62.0 | (206.8) |
Net income (loss) | $ (140.6) | $ (68.9) | $ (162.6) |
Basic | |||
Continuing operations (in dollars per share) | $ (0.97) | $ (0.98) | $ 0.32 |
Discontinued operations (in dollars per share) | (0.07) | 0.46 | (1.52) |
Basic (in dollars per share) | (1.04) | (0.52) | (1.20) |
Diluted | |||
Continuing operations (in dollars per share) | (0.97) | (0.98) | 0.32 |
Discontinued operations (in dollars per share) | (0.07) | 0.46 | (1.51) |
Diluted (in dollars per share) | $ (1.04) | $ (0.52) | $ (1.19) |
Weighted-average shares outstanding | |||
Basic (in shares) | 134.5 | 133.6 | 136.1 |
Diluted (in shares) | 134.5 | 133.6 | 137.2 |
Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Assets | ||
Cash and cash equivalents | $ 600.7 | $ 1,864.9 |
Accounts receivable, net of allowance for credit losses of $6.8 and $7.2, respectively | 697.1 | 652.9 |
Inventories | 1,150.3 | 1,020.2 |
Prepaid expenses and other current assets | 271.8 | 305.8 |
Current assets held for sale | 0.0 | 16.1 |
Total current assets | 2,719.9 | 3,859.9 |
Property, plant and equipment, net | 926.3 | 864.1 |
Operating lease assets | 217.1 | 166.9 |
Goodwill and indefinite-lived intangible assets | 3,549.0 | 3,004.7 |
Definite-lived intangible assets, net | 3,230.2 | 2,146.1 |
Deferred income taxes | 7.1 | 6.5 |
Other non-current assets | 367.7 | 377.5 |
Total non-current assets | 8,297.4 | 6,565.8 |
Total assets | 11,017.3 | 10,425.7 |
Liabilities and Shareholders’ Equity | ||
Accounts payable | 537.3 | 411.2 |
Payroll and related taxes | 136.4 | 118.5 |
Accrued customer programs | 139.1 | 125.6 |
Other accrued liabilities | 250.2 | 279.4 |
Accrued income taxes | 14.4 | 16.5 |
Current indebtedness | 36.2 | 603.8 |
Current liabilities held for sale | 0.0 | 32.9 |
Total current liabilities | 1,113.6 | 1,587.9 |
Long-term debt, less current portion | 4,070.4 | 2,916.7 |
Deferred income taxes | 368.2 | 239.3 |
Other non-current liabilities | 623.0 | 530.1 |
Total non-current liabilities | 5,061.6 | 3,686.1 |
Total liabilities | 6,175.2 | 5,274.0 |
Contingencies - Refer to Note 19 | ||
Controlling interests: | ||
Preferred shares, $0.0001 par value per share, 10 shares authorized | 0.0 | 0.0 |
Ordinary shares, €0.001 par value per share, 10,000 shares authorized | 6,936.7 | 7,043.2 |
Accumulated other comprehensive income | (27.0) | 35.5 |
Retained earnings (accumulated deficit) | (2,067.6) | (1,927.0) |
Total shareholders’ equity | 4,842.1 | 5,151.7 |
Total liabilities and shareholders' equity | $ 11,017.3 | $ 10,425.7 |
Supplemental Disclosures of Balance Sheet Information | ||
Preferred shares, issued and outstanding | 0.0 | 0.0 |
Ordinary shares, issued and outstanding | 134.7 | 133.8 |